Introduction
Amphetamine products, including those with the NDC code 0185-0842, are widely used for treating conditions such as Attention Deficit Hyperactivity Disorder (ADHD) and certain types of narcolepsy. Here, we will delve into the market analysis and price projections for these medications.
Market Overview
The pharmaceutical market, particularly for amphetamine products, is subject to various factors that influence pricing and demand.
- Biopharma and Biotech Growth: The biopharma market, which includes amphetamine products, is projected to grow significantly. As of 2024, the biopharma market size was estimated to be over $400 billion with a compound annual growth rate (CAGR) of 7.56% between 2024 and 2029[3].
Drug Pricing Trends
Drug prices, especially in the U.S., have been a subject of concern due to their high and increasing costs.
- U.S. vs. International Prices: Prescription drug prices in the U.S. are significantly higher than in other high-income countries. For example, U.S. prices for brand-name drugs were 422% of prices in comparison countries, even after adjusting for rebates and discounts[4].
Specifics of Amphetamine Products (NDC: 0185-0842)
The product with NDC code 0185-0842 is a mixed salts amphetamine product, specifically dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets, marketed by Sandoz Inc.
- DEA Schedule and Abuse Potential: These products are classified as DEA Schedule CII, indicating a high potential for abuse and misuse[1][5].
Price Projections
Several factors influence the price projections for these amphetamine products:
-
Overall Drug Price Inflation: Vizient projects a 3.8% increase in drug prices in 2024, driven partly by specialty pharmaceuticals, including weight loss drugs and gene therapies. This is the highest projected increase since July 2019[2].
-
Market Dynamics: The increasing utilization of specialty drugs and the expansion of gene therapies are expected to drive up costs. Hospitals and healthcare providers are facing challenges in managing pharmacy expenditures due to rising drug costs and drug shortages[2].
Regulatory and Clinical Trial Impacts
Changes in regulatory frameworks and clinical trial designs can also affect pricing and market dynamics.
- Innovative Clinical Trial Designs: There is a shift towards more efficient and innovative clinical trial designs, which could impact the development and pricing of new drugs. This includes a focus on patient-centered care and the use of AI/ML technologies[3].
Supply Chain and Expenditure Management
Managing pharmacy expenditures and strengthening the supply chain are crucial due to the rising costs and potential shortages.
- Challenges in 2023: Many hospitals experienced drug shortages and rising drug costs in 2023, highlighting the need for effective expenditure management and supply chain strengthening[2].
International Price Comparisons
The high prices of prescription drugs in the U.S. compared to other countries are a significant concern.
- Price Index Approach: Studies using a price index approach have shown that U.S. prices for prescription drugs are nearly three times as high as prices in other OECD countries. For brand-name drugs, U.S. prices were 422% of prices in comparison countries[4].
Impact on Consumers and Healthcare Systems
The high and increasing costs of amphetamine products and other prescription drugs have significant implications for consumers and healthcare systems.
-
Consumer Burden: Consumers in the U.S. pay substantially more for prescription drugs compared to consumers in other high-income countries. This can lead to financial burdens and reduced access to necessary medications[4].
-
Healthcare System Costs: The rising costs of prescription drugs contribute to increased healthcare expenditures, affecting both public and private healthcare systems[4].
Key Takeaways
- The biopharma market, including amphetamine products, is expected to grow significantly.
- Drug prices in the U.S. are higher than in other countries and are projected to increase further.
- Effective management of pharmacy expenditures and supply chains is crucial due to rising costs and potential shortages.
- Regulatory changes and innovative clinical trial designs may impact drug development and pricing.
- The high cost of prescription drugs in the U.S. has significant implications for consumers and healthcare systems.
FAQs
1. What is the NDC code 0185-0842 for?
The NDC code 0185-0842 is for dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate tablets, a mixed salts amphetamine product used to treat ADHD and narcolepsy.
2. Why are drug prices in the U.S. so high?
Drug prices in the U.S. are significantly higher than in other countries due to various factors, including faster growth in U.S. prices, changes in the mix of drugs, and the absence of price controls.
3. What is the projected increase in drug prices for 2024?
Vizient projects a 3.8% increase in drug prices in 2024, driven by specialty pharmaceuticals and gene therapies.
4. How do regulatory changes affect drug pricing?
Regulatory changes, such as evolving clinical trial designs and shifts towards patient-centered care, can impact the development and pricing of new drugs.
5. What are the implications of high drug prices for consumers?
High drug prices can lead to financial burdens for consumers and reduced access to necessary medications, particularly in the U.S. where prices are significantly higher than in other countries.
Cited Sources
- DailyMed: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE tablet.
- Vizient: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
- TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025.
- ASPE: International Prescription Drug Price Comparisons: Estimates Using IQVIA MIDAS Data.
- PharmaCompass: NDC Code 0185-0864-01 - Amphetamine.